glp-1 colorectal cancer death risk study november 2025 Mapping the effectiveness and risks of receptor agonists Full article: The Influence of

Non-alcoholic fatty liver disease and socioeconomic determinants in an Iranian cohort study

Additional laboratory studies continue to evaluate the peptides influence on oxidative stress signaling, inflammatory pathways, and cellular repair mechanisms

I see glp-1-base therapies as something to jumpstart the weight loss journey making the transition to the more sustainable ones, e.g

While some side effects have been seen (gastrointestinal disorders, hypotension, syncope, arthritic disorders, etc.), theyre at doses far exceeding what Ruhoy and Kaufman are using, and they have not seen these side effects in their patients